iBio (IBIO) Cash from Investing Activities (2016 - 2025)
iBio (IBIO) has disclosed Cash from Investing Activities for 16 consecutive years, with -$3.0 million as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities fell 149050.0% to -$3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.4 million through Dec 2025, down 1659.99% year-over-year, with the annual reading at $742000.0 for FY2025, 18.1% down from the prior year.
- Cash from Investing Activities for Q4 2025 was -$3.0 million at iBio, up from -$21.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $8.2 million in Q1 2023, with the low at -$21.5 million in Q3 2025.
- Average Cash from Investing Activities over 5 years is -$1.5 million, with a median of -$6000.0 recorded in 2023.
- The sharpest move saw Cash from Investing Activities surged 1494.0% in 2023, then plummeted 149050.0% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$972000.0 in 2021, then dropped by 29.12% to -$1.3 million in 2022, then soared by 103.98% to $50000.0 in 2023, then crashed by 104.0% to -$2000.0 in 2024, then tumbled by 149050.0% to -$3.0 million in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$3.0 million, -$21.5 million, and $45000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.